Gene therapy in disorders of lipoprotein metabolism

Current Gene Therapy

Volumn 7, Issue 1, 2007, Pages 35-47

  Vaessen, Stefan F C ^a   Twisk, Jaap ^b   Kastelein, John J P ^a   Kuivenhoven, Jan Albert ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Amsterdam Molecular Therapeutics   (Netherlands)

Author keywords

(Helper dependent) Adenovirus; Adeno associated virus; Apolipoprotein AI; Familial hypercholesterolemia; HDL; LDL; Lipoprotein lipase; Triglycerides

Indexed keywords

ABC TRANSPORTER A1; ADENOVIRUS VECTOR; ANTISENSE OLIGONUCLEOTIDE; APOLIPOPROTEIN A1; APOLIPOPROTEIN A5; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; CHOLESTEROL 7ALPHA MONOOXYGENASE; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISIS 301012; LENTIVIRUS VECTOR; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PARVOVIRUS VECTOR; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PLASMID DNA; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

AMNION CELL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL BASED GENE THERAPY; CLINICAL TRIAL; DYSLIPIDEMIA; EMBRYONIC STEM CELL; FAMILIAL HYPERCHOLESTEROLEMIA; FEASIBILITY STUDY; GENE OVEREXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPOPROTEINEMIA; LOW FAT DIET; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; REVIEW; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; APOLIPOPROTEINS B; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CRICETINAE; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MALE; MICE; RABBITS; TRIGLYCERIDES;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE;

EID: 33847367365     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652307779940261     Document Type: Review

References (114)

1. Alba, R., Bosch, A. and Chillon, M. (2005) Gutless adenovirus: last-generation adenovirus for gene therapy. Gene. Ther., 12 Suppl 1: S18-S27.
2. Awasthi, V. D., Garcia, D., Goins, B. A. and Phillips, W. T. (2003) Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits. Int. J. Pharm., 253: 121-132.
3. Belalcazar, L. M., Merched, A., Carr, B., Oka, K., Chen, K. H., Pastore, L., Beaudet, A. and Chan, L. (2003) Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation, 107: 2726-2732.
4. Benoit, P., Emmanuel, F., Caillaud, J. M, Bassinet, L., Castro, G., Gallix, P., Fruchart, J. C., Branellec, D., Denefle, P. and Duverger, N. (1999) Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models. Circulation, 99: 105-110.
5. Broedl, U. C. and Rader, D. J. (2005) Gene therapy for lipoprotein disorders. Expert Opin. Biol. Ther., 5: 1029-1038.
6. Brown, D. R., Brousseau, M. E., Shamburek, R. D., Talley, G. D., Meyn, S., Demosky, S. J. Jr., Santamarina-Fojo, S., Brewer, H. B, Jr. and Hoeg, J. M. (1996) Adenoviral delivery of low-density lipoprotein receptors to hyperlipidemic -rabbits: receptor expression modulates high-density lipoproteins. Metabolism, 45: 1447-1457.
7. Chen, S. J., Rader, D. J., Tazelaar, J., Kawashiri, M., Gao, G. and Wilson, J. M. (2000) Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipoprotein receptor. Mol. Ther., 2: 256-261.
8. Chiesa, G. and Sirtori, C. R. (2003) Apolipoprotein A-I(Milano): current perspectives. Curr. Opin. Lipidol., 14: 159-163.
9. Chowdhury, J. R., Grossman, M., Gupta, S., Chowdhury, N. R., Baker, J. R. Jr. and Wilson, J. M. (1991) Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science, 254: 1802-1805.
10. Cichon, G., Willnow, T., Herwig, S., Uckert., W., Loser, P., Schmidt, H. H., Benhidjeb, T., Schlag, P. M., Schnieders, F., Niedzielska, D. and Heeren, J. (2004) Non-physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage. J. Gene Med., 6: 166-175.
11. Crooke, R. M., Graham, M. J., Lemonidis, K. M., Whipple, C. P., Koo, S. and Perera, R. J. (2005) An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis. J. Lipid. Res., 46: 872-884.
12. Daemen, T., de, M. A, Bungener, L., de, J. J., Huckriede, A. and Wilschut, J. (2005) Virosomes for antigen and DNA delivery. Adv. Drug. Deliv. Rev., 57: 451-463.
13. De Geest, B., Stengel, D., Landeloos, M., Lox, M., Le Gat, L., Collen, D., Holvoet, P. and Ninio, E. (2000a) Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis. Arterioscler. Thromb. Vasc. Biol., 20: E68-E75.
14. De Geest, B., Van Linthout, S. and Collen, D. (2001) Sustained expression of human apo A-I following adenoviral gene transfer in mice. Gene Ther., 8: 121-127.
15. De Geest, B., Van Linthout, S., Lox, M., Collen, D. and Holvoet, P. (2000b) Sustained expression of human apolipoprotein A-I after adenoviral gene transfer in C57BL/6 mice: role of apolipoprotein A-I promoter, apolipoprotein A-I introns. and human apolipoprotein E enhancer. Hum. Gene Ther., 11: 101-112.
16. De Geest, B., Zhao, Z., Collen, D. and Holvoet, P. (1997) Effects of adeno-virus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient mice. Circulation, 96: 4349-4356.
17. De Geest, B. R., Van Linthout, S. A. and Collen, D. (2003) Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells. Blood, 101: 2551-2556.
18. Dichek, D. A., Bratthauer, G. L., Beg, Z. H. Anderson, K. D, Newman, K. D., Zwiebel, J. A., Hoeg, J. M. and Anderson, W. F. (1991) Retroviral vector-mediated in vivo expression of low-density-lipoprotein receptors in the Watanabe heritable hyperlipidemic rabbit. Somat. Cell Mol. Genet., 17: 287-301.
19. Enjoji, M., Wang, F., Nakamuta, M., Chan, L. and Teng, B. B. (2000) Hammerhead ribozyme as a therapeutic agent for hyperlipidemia: production of truncated apolipoprotein B and hypolipidemic effects in a dyslipidemia murine model. Hum. Gene Ther., 11: 2415-2430.
20. Excoffon, K. J., Liu, G., Miao, L., Wilson, J. E., McManus, B. M., Semenkovich, C. F., Coleman, T., Benoit, P., Duverger, N., Branellec, D., Denefle, P., Hayden, M. R. and Lewis, M. E. (1997) Correction of hypertriglyceridemia and impaired fat tolerance in lipoprotein lipase-deficient mice by adenovirus-mediated expression of human lipoprotein lipase. Arterioscler. Thromb. Vasc. Biol., 17: 2532-2539.
21. Fan, L., Drew, J., Dunckley, M. G., Owen, J. S. and Dickson, G. (1998) Efficient coexpression and secretion of anti-atherogenic human apolipoprotein AI and lecithin-cholesterol acyltransferase by cultured muscle cells using adeno-associated virus plasmid vectors. Gene. Ther., 5: 1434-1440.
22. Fan, L. Owen, J. S. and Dickson, G. (1999) Construction and characterization of polycistronic retrovirus vectors for sustained and high-level co-expression of apolipoprotein A-I and lecithin-cholesterol acyltransferase. Atherosclerosis, 147: 139-145.
23. Felnerova, D., Viret, J. F., Gluck, R. and Moser, C. (2004) Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Curr. Opin. Biotechnol., 15: 518-529.
24. Frolkis, V. V., Kulchitsky, O. K., Kordjum, V. A., Novikova, S. N., Sikalo, N. V., Potapenko, R. I., Irodov, D. M., Bogatskaya, L. N., Burchinskaya, M. K. and Mozzhukhina, T. G. (1998) Effect of implantation of human apoAI gene on apoprotein composition and vasoactive properties of high-density lipoproteins in rats at different ages. Mech. Ageing. Dev., 101: 213-219.
25. Gao, G. P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J. and Wilson, J. M. (2002) Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA, 99: 11854-11859.
26. Goldstein, J. L., Hobbs, H. H. and Brown, M. S. (2001) Familiar hypercholesterolemia. In: The metabolic and molecular basis of inherited disease, Eds. Scriver, C.R, Beauder, A.L, Sly, W.S. and Valle D. McGraw-Hill, New York, pp. 2863-2913.
27. Greeve, J., Jona, V. K., Chowdhury, N. R., Horwitz, M. S. and Chowdhury, J. R. (1996) Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits. J. Lipid Res., 37: 2001-2017.
28. Grossman, M., Rader, D. J., Muller, D. W., Kolansky, D. M., Kozarsky, K., Clark, B. J. III., Stein, E. A., Lupien, P. J., Brewer, H. B. Jr., Raper, S. E. (1995) A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat. Med., 1: 1148-1154.
29. Grossman, M., Raper, S. E., Kozarsky, K., Stein, E. A., Engelhardt, J. F., Muller, D., Lupien, P. J. and Wilson, J. M. (1994) Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat. Genet., 6: 335-341.
30. Groth, A. C., Olivares, E. C., Thyagarajan, B. and Calos, M. P. (2000) A phage integrase directs efficient site-specific integration in human cells. Proc. Natl. Acad. Sci. U S. A., 97: 5995-6000.
31. Hamada, K., Sakaue, M., Sarkar, A., Buchl, S., Satterfield, W., Keeling, M., Sastry, J., Roth, J. A. and Follen, M. (2005) Immune responses to repetitive adenovirus-mediated gene transfer and restoration of gene expression by cyclophosphamide or etoposide. Gynecol. Oncol., 99: S177-S186.
32. Heeren, J., Steinwaerder, D. S., Schnieders, F., Cichon, G., Strauss, M. and Beisiegel, U. (1999) Nonphysiological overexpression of low-density lipoprotein receptors causes pathological intracellular lipid accumulation and the formation of cholesterol and cholesteryl ester crystals in vitro. J. Mol. Med., 77: 735-743.
33. Herz, J. and Gerard, R. D. (1993) Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. U. S. A., 90: 2812-2816.
34. Huang, W., Bi, N., Zhang, X., Wang, Y., Chen, B. and Liu, G. (2006) Overexpression of apolipoprotein AV in the liver reduces plasma triglyceride and cholesterol but not HDL in ApoE deficient mice. Biochem. Biophys. Res. Commun., 346: 14-18.
35. Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E. and Herz, J. (1993) Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest., 92: 883-893.
36. Izsvak, Z. and Ivics, Z. (2004) Sleeping beauty transposition: biology and applications for molecular therapy. Mol. Ther., 9: 147-156.
37. Kankkonen, H. M., Vahakangas, E., Marr, R. A., Pakkanen, T., Laurema, A., Leppanen, P., Jalkanen, J., Verma, I. M. and Yla-Herttuala, S. (2004) Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy. Mol. Ther., 9: 548-556.
38. Kastelein, J. J. P., Wedel, M. K., Baker, B. F., Su, J., Bradley, J. D., Yu, R. Z., Chuang, E., Graham, M. J. and Crooke, R. M. (2006) Potent reduction of apolipoprotein B and LDL cholesterol by an antisense inhibitor of apolipoprotein B. Circulation, 114: 1729-1735.
39. Kingsley, D. M., Sege, R. D., Kozarsky, K. F. and Krieger, M. (1986) DNA-mediated transfer of a human gene required for low-density lipoprotein receptor expression and for multiple Golgi processing pathways. Mol. Cell Biol., 6: 2734-2737.
40. Kitajima, K., Miller, G. C., Gao, G., Marchadier, D. H., Wilson, J. M. and Rader, D. J. (2005) Long-term and high level hepatic apoA-I expression using vectors based on adenoassociated virus 7 and 8. Circulation, 112: II-178-II-179.
41. Kobayashi, K., Oka, K., Forte, T., Ishida, B., Teng, B., Ishimura-Oka, K., Nakamuta, M. and Chan, L. (1996) Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. J. Biol. Chem., 271: 6852-6860.
42. Kopfler, W. P., Willard, M., Betz, T., Willard, J. E., Gerard, R. D. and Meidell, R. S. (1994) Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol. Circulation, 90: 1319-1327.
43. Kozarsky, K. F., Bonen, D. K., Giannoni, F., Funahashi, T., Wilson, J. M. and Davidson, N. O. (1996a) Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits. Hum. Gene Ther., 7: 943-957.
44. Kozarsky, K. F., Jooss, K., Donahee, M., Strauss, J. F. III. and Wilson, J. M. (1996b) Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nat. Genet., 13: 54-62.
45. Kozarsky, K. F., McKinley, D. R., Austin, L. L., Raper, S. E., Stratford-Perricaudet, L. D. and Wilson, J. M. (1994) In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem., 269: 13695-13702.
46. Lebherz, C., Gao, G., Louboutin, J. P., Millar, J., Rader, D. and Wilson, J. M. (2004) Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia. J. Gene Med., 6: 663-672.
47. Lewis, M. E., Forsythe, I. J., Marth, J. D., Brunzell, J. D., Hayden, M. R. and Humphries, R. K. (1995) Retroviral-mediated gene transfer and expression of human lipoprotein lipase in somatic cells. Hum. Gene Ther., 6: 853-863.
48. Li, J., Fang, B., Eisensmith, R. C., Li, X. H. Nasonkin, I., Lin-Lee, Y. C., Mims, M. P., Hughes, A., Montgomery, C. D., Roberts, J. D. (1995) In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene. J. Clin. Invest., 95: 768-773.
49. Liao, W. and Ning, G. (2006) Knockdown of apolipoprotein B, an atherogenic apolipoprotein, in HepG2 cells by lentivirus-mediated siRNA. Biochem. Biophys. Res. Commun., 344: 478-483.
50. Liu, G., Ashbourne Excoffon, K. J., Wilson, J. E., McManus, B. M., Rogers, Q. R., Miao, L., Kastelein, J. J., Lewis, M. E. and Hayden, M. R. (2000) Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transfer. Hum. Gene Ther., 11: 21-32.
51. Liu, G., Excoffon, K. J., Benoit, P., Ginzinger, D. G., Miao, L., Ehrenborg, E., Duverger, N., Denefle, P. P., Hayden, M. R. and Lewis, M. E. (1997) Efficient adenovirus-mediated ectopic gene expression of human lipoprotein lipase in human hepatic (HepG2) cells. Hum. Gene Ther., 8: 205-214.
52. Liu, G., Excoffon, K. J., Wilson, J. E., McManus, B. M., Miao, L., Benoit, P., Duverger, N., Branellec, D., Denefle, P., Hayden, M. R. and Lewis, M. E. (1998) Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer. Clin. Invest. Med., 21: 172-185.
53. Lv, H., Zhang, S., Wang, B., Cui, S. and Yan, J. (2006) Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release., 114: 100-109.
54. MacDougall, E. D., Kramer, F., Polinsky, P., Barnhart, S., Askari, B., Johansson, F., Varon, R., Rosenfeld, M. E., Oka, K., Chan, L., Schwartz, S. M. and Bornfeldt, K. E. (2006) Aggressive Very Low-Density Lipoprotein (VLDL) and LDL Lowering by Gene Transfer of the VLDL Receptor Combined with a Low-Fat Diet Regimen Induces Regression and Reduces Macrophage Content in Advanced Atherosclerotic Lesions in LDL Receptor-Deficient Mice. Am. J. Pathol., 168: 2064-2073.
55. Manning, W. C., Zhou, S., Bland, M. P., Escobedo, J. A. and Dwarki, V. (1998) Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors. Hum. Gene Ther., 9: 477-485.
56. Manno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., Dake, M., Kaye, R., Razavi, M., Zajko, A., Zehnder, J., Rustagi, P. K., Nakai, H., Chew, A., Leonard, D., Wright, J. F., Lessard, R. R., Sommer, J. M., Tigges, M., Sabatino, D., Luk, A., Jiang, H., Mingozzi, F., Couto, L., Ertl, H. C, High, K. A. and Kay, M. A. (2006) Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med., 12: 342-347.
57. Marcais, C., Verges, B., Charriere, S., Pruneta, V., Merlin, M., Billon, S., Perrot, L., Drai, J., Sassolas, A., Pennacchio, L. A., Fruchart-Najib, J., Fruchart, J. C., Durlach, V. and Moulin, P. (2005) Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J. Clin. Invest., 115: 2862-2869.
58. McCarty, D. M., Fu, H., Monahan, P. E., Toulson, C. E., Naik, P. and Samulski, R. J. (2003) Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther., 10: 2112-2118.
59. Menendez, P., Wang, L. and Bhatia, M. (2005) Genetic manipulation of human embryonic stem cells: a system to study early human development and potential therapeutic applications. Curr. Gene Ther., 5: 375-385.
60. Mertens, A., Verhamme, P., Bielicki, J. K., Phillips, M. C., Quarck, R., Verreth, W., Stengel, D., Ninio, E., Navab, M., Mackness, B., Mackness, M. and Holvoet, P. (2003) Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Circulation, 107: 1640-1646.
61. Miao, C. H. (2005) A novel gene expression system: non-viral gene transfer for hemophilia as model systems. Adv. Genet., 54: 143-177.
62. Miyanohara, A., Sharkey, M. F., Witztum, J. L., Steinberg, D. and Friedmann, T. (1988) Efficient expression of retroviral vector-transduced human low density lipoprotein (LDL) receptor in LDL receptor-deficient rabbit fibroblasts in vitro. Proc. Natl. Acad. Sci. U. S. A., 85: 6538-6542.
63. Naoumova, R. P., Thompson, G. R. and Soutar, A. K. (2004) Current management of severe homozygous hypercholesterolaemias. Curr. Opin. Lipidol., 15: 413-422.
64. Nathwani, A. C., Gray, J. T., McIntosh, J., Ng, C. Y., Zhou, J., Spence, Y., Cochrane, M., Gray, E., Tuddenham, E. G. and Davidoff, A. M. (2006) Safe and efficient transduction of the liver after peripheral vein infusion of self complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates. Blood In press.
65. Nomura, S., Merched, A., Nour, E., Dieker, C., Oka, K. and Chan, L. (2004) Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia. Gene Ther., 11: 1540-1548.
66. O'Riordan, C. R., Lachapelle, A., Delgado, C., Parkes, V., Wadsworth, S. C., Smith, A. E. and Francis, G. E. (1999) PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum. Gene Ther., 10: 1349-1358.
67. Oka, K., Belalcazar, L. M., Dieker, C., Nour, E. A., Nuno-Gonzalez, P., Paul, A., Cormier, S., Shin, J. K., Finegold, M. and Chan, L. (2006) Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector. Gene Ther, In press.
68. Oka, K., Pastore, L., Kim, I. H., Merched, A., Nomura, S., Lee, H. J., Merched-Sauvage, M., Arden-Riley, C., Lee, B., Finegold, M., Beaudet, A. and Chan, L. (2001) Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor. Circulation, 103: 1274-1281.
69. Oliva, C. P., Pisciotta, L., Guardamagna, O., Bellocchio, A., Tarugi, P., Schaap, F. G., Bertolini, S. and Calandra, S. (2006) A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia. Atherosclerosis, 188: 215-217.
70. Oliva, C. P., Pisciotta, L., Li, V. G., Sambataro, M. P., Cantafora, A., Bellocchio, A., Catapano, A., Tarugi, P., Bertolini, S. and Calandra, S. (2004) Inherited Apolipoprotein A-V Deficiency in Severe Hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol., 25: 411-417.
71. Pages, J. C., Andreoletti, M., Bennoun, M., Vons, C., Elcheroth, J., Lehn, P., Houssin, D., Chapman, J., Briand, P., Benarous, R. (1995) Efficient retroviral-mediated gene transfer into primary culture of murine and human hepatocytes: expression of the LDL receptor. Hum. Gene Ther., 6: 21-30.
72. Pakkanen, T. M., Laitinen, M., Hippelainen, M., Kallionpaa, H., Lehtolainen, P., Leppanen, P., Luoma, J. S., Tarvainen, R., Alhava, E. and Yla-Herttuala, S. (1999) Enhanced plasma cholesterol lowering effect of retrovirus-mediated LDL receptor gene transfer to WHHL rabbit liver after improved surgical technique and stimulation of hepatocyte proliferation by combined partial liver resection and thymidine kinase-ganciclovir treatment. Gene Ther., 6: 34-41.
73. Parks, R., Evelegh, C. and Graham, F. (1999) Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration. Gene Ther., 6: 1565-1573.
74. Pastore, L., Belalcazar, L. M., Oka, K., Cela, R., Lee, B., Chan, L. and Beaudet, A. L. (2004) Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice. Gene, 327: 153-160.
75. Pennacchio, L. A., Olivier, M., Hubacek, J. A., Cohen, J. C, Cox, D. R., Fruchart, J. C., Krauss, R. M. and Rubin, E. M. (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science, 294: 169-173.
76. Pritchard, P. H. and Hill, J. S. (1999) Genetic disorders of lecithin: cholesterol acytransferase. In: Lipoproteins in health and disease, Eds. Betteridge, D.J, Illingworth, D.R. and Shepherd, J. Oxford University Press, New York, pp. 799-814.
77. Razzini, G., Parise, F., Calebiro, D., Battini, R., Bagni, B., Corazzari, T., Tarugi, P., Angelelli, C., Molinari, S., Falqui, L. and Ferrari, S. (2004) Low-density lipoprotein (LDL) receptor/transferrin fusion protein: in vivo production and functional evaluation as a potential therapeutic tool for lowering plasma LDL cholesterol. Hum. Gene Ther., 15: 533-541.
78. Reardon, C. A., Kan, H. Y., Cabana, V., Blachowicz, L., Lukens, J. R., Wu, Q., Liadaki, K., Getz, G. S. and Zannis, V. I. (2001) In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of ApoA-I mutants in ApoA-I-deficient mice. Biochemistry, 40: 13670-13680.
79. Rip, J., Nierman, M. C., Ross, C. J., Jukema, J. W., Hayden, M. R., Kastelein, J. J., Stroes, E. S. and Kuivenhoven, J. A. (2006) Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. Arterioscler. Thromb. Vasc. Biol., 26: 1236-1245.
80. Rip, J., Nierman, M. C., Sierts, J. A., Petersen, W., van den, O. K., Van Raalte, D., Ross, C. J., Hayden, M. R., Bakker, A. C., Dijkhuizen, P., Hermens, W. T., Twisk, J., Stroes, E., Kastelein, J. J., Kuivenhoven, J. A. and Meulenberg, J. M. (2005) Gene therapy for lipoprotein lipase deficiency: working toward clinical application. Hum. Gene Ther., 16: 1276-1286.
81. Ross, C. J., Liu, G., Kuivenhoven, J. A., Twisk, J., Rip, J., van Dop, W., Excoffon, K. J., Lewis, S. M., Kastelein, J. J. and Hayden, M. R. (2005) Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation. Arterioscler. Thromb. Vasc. Biol., 25: 2143-2150.
82. Ross, C. J., Twisk, J., Bakker, A. C., Miao, F., Verbart, D., Rip, J., Godbey, T., Dijkhuizen, P., Hermens, W. T., Kastelein, J. J., Kuivenhoven, J. A, Meulenberg, J. M. and Hayden, M. R. (2006) Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation. Hum. Gene Ther., 17: 487-499.
83. Ross, C. J., Twisk, J., Meulenberg, J. M., Liu, G., van den, O. K., Moraal, E., Hermens, W. T., Rip, J., Kastelein, J. J., Kuivenhoven, J. A. and Hayden, M. R. (2004) Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation. Hum. Gene Ther., 15: 906-919.
84. Schaap, F. G., Rensen, P. C., Voshol, P. J., Vrins, C., van der Vliet, H. N., Chamuleau, R. A., Havekes, L. M., Groen, A. K. and van Dijk, K. W. (2004) ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J. Biol. Chem., 279: 27941-27947.
85. Seguret-Mace, S., Latta-Mahieu, M., Castro, G., Luc, G., Fruchart, J. C., Rubin, E., Denefle, P. and Duverger, N. (1996) Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene. Circulation, 94: 2177-2184.
86. Sharifi, B. G., Wu, K., Wang, L., Ong, J. M., Zhou, X. and Shah, P. K. (2005) AAV serotype-dependent apolipoprotein A-I Milano gene expression. Atherosclerosis, 181: 261-269.
87. Shichiri, M., Tanaka, A. and Hirata, Y. (2003) Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex. Gene Ther., 10: 827-831.
88. Smith, T. A., White, B. D., Gardner, J. M., Kaleko, M. and McClelland, A. (1996) Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. Gene Ther., 3: 496-502.
89. Spady, D. K., Cuthbert, J. A., Willard, M. N. and Meidell, R. S. (1995) Adenovirus-mediated transfer of a gene encoding cholesterol 7 alpha-hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol. J. Clin. Invest., 96: 700-709.
90. Spady, D. K., Cuthbert, J. A., Willard, M. N. and Meidell, R. S. (1998) Overexpression of Cholesterol 7alpha -Hydroxylase (CYP7A) in Mice Lacking the Low Density Lipoprotein (LDL) Receptor Gene. LDL transport and plasma LDL concentrations are reduced. J. Biol. Chem., 273: 126-132.
91. Stein, C. S., Martins, I. and Davidson, B. L. (2000) Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade. J. Gene Med., 2: 41-51.
92. Strauss, J. G., Frank, S., Kratky, D., Hammerle, G., Hrzenjak, A., Knipping, G., von Eckardstein, A., Kostner, G. M. and Zechner, R. (2001) Adenovirus-mediated rescue of lipoprotein lipase-deficient mice. Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice. J. Biol. Chem., 276: 36083-36090.
93. Takahashi, S., Ohsugi, K., Yamamoto, T., Shiomi, M. and Sakuragawa, N. (2001) A novel approach to ex vivo gene therapy for familial hypercholesterolemia using human amniotic epithelial cells as a transgene carrier. Tohoku. J. Exp. Med., 193: 279-292.
94. Tangirala, R. K., Tsukamoto, K., Chun, S. H., Usher, D., Pure, E. and Rader, D. J. (1999) Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation, 100: 1816-1822.
95. Teng, B., Blumenthal, S., Forte, T., Navaratnam, N., Scott, J., Gotto, A. M. Jr. and Chan, L. (1994) Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J. Biol. Chem., 269: 29395-29404.
96. Teng, B., Ishida, B., Forte, T. M., Blumenthal, S., Song, L. Z., Gotto, A. M. Jr. and Chan, L. (1997) Effective Lowering of Plasma, LDL. and Esterified Cholesterol in LDL ReceptorûKnockout Mice by Adenovirus-Mediated Gene Delivery of ApoB mRNA Editing Enzyme (Apobecl). Arterioscler. Thromb. Vasc. Biol., 17: 889-897.
97. Tsukamoto, K., Hiester, K. G., Smith, P., Usher, D. C., Glick, J. M. and Rader, D. J. (1997) Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus. J. Lipid Res., 38: 1869-1876.
98. van der Vliet, H. N., Sammels, M. G., Leegwater, A. C., Levels, J. H., Reitsma, P. H., Boers, W. and Chamuleau, R. A. (2001) Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J. Biol. Chem., 276: 44512-44520.
99. van der Vliet, H. N., Schaap, F. G., Levels, J. H., Ottenhoff, R., Looije, N., Wesseling, J. G., Groen, A. K. and Chamuleau, R. A. (2002) Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. Biochem. Biophys. Res. Commun., 295: 1156-1159.
100. Van Linthout, S., Collen, D. and De Geest, B. (2002a) Effect of promoters and enhancers on expression, transgene DNA persistence. and hepatotoxicity after adenoviral gene transfer of human apolipoprotein A-I. Hum. Gene. Ther., 13: 829-840.
101. Van Linthout, S., Lusky, M., Collen, D. and De Geest, B. (2002b) Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector. Gene Ther., 9: 1520-1528.
102. Wade-Martins, R., Saeki, Y. and Chiocca, E. A. (2003) Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells. Mol. Ther., 7: 604-612.
103. Wang, J. P., Enjoji, M., Tiebel, M., Ochsner, S., Chan, L. and Teng, B. B. (1999) Hammerhead ribozyme cleavage of apolipoprotein B mRNA generates a truncated protein. J. Biol. Chem., 274: 24161-24170.
104. Wang, Y., Hallden, G., Hill, R., Anand, A., Liu, T. C., Francis, J., Brooks, G., Lemoine, N. and Kirn, D. (2003a) E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models. Nat. Biotechnol., 21: 1328-1335.
105. Wang, Z., Ma, H. I., Li, J., Sun, L., Zhang, J. and Xiao, X. (2003b) Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene. Ther., 10: 2105-2111.
106. Wellington, C. L., Brunham, L. R., Zhou, S., Singaraja, R. R., Visscher, H., Gelfer, A., Ross, C., James, E., Liu, G., Huber, M. T., Yang, Y. Z, Parks, R. J., Groen, A., Fruchart-Najib, J. and Hayden, M. R. (2003) Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1. J. Lipid Res., 44: 1470-1480.
107. Wilson, J. M., Chowdhury, N. R., Grossman, M., Wajsman, R., Epstein, A., Mulligan, R. C. and Chowdhury, J. R. (1990) Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. Proc. Natl. Acad. Sci. U. S. A., 87: 8437-8441.
108. Wilson, J. M., Grossman, M., Wu, C. H., Chowdhury, N. R., Wu, G. Y. and Chowdhury, J. R. (1992) Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits. J. Biol. Chem., 267: 963-967.
109. Wilson, J. M., Johnston, D. E., Jefferson, D. M. and Mulligan, R. C. (1988) Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. U. S. A., 85: 4421-4425.
110. Wu, Z., Asokan, A. and Samulski, R. J. (2006) Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol. Ther., 14: 316-327.
111. Zhang, Y., Chirmule, N., Gao, G. P., Qian, R., Croyle, M., Joshi, B., Tazelaar, J. and Wilson, J. M. (2001) Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol. Ther., 3: 697-707.
112. Zhang, Y., Zanotti, I., Reilly, M. P., Glick, J. M., Rothblat, G. H. and Rader, D. J. (2003) Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Circulation, 108: 661-663.
113. Zhong, S., Sun, S. and Teng, B. B. (2004) The recombinant adeno-associated virus vector (rAAV2)-mediated apolipoprotein B mRNA-specific hammerhead ribozyme: a self-complementary AAV2 vector improves the gene expression. Genet. Vaccines Ther., 2: 5-
114. Zsigmond, E., Kobayashi, K., Tzung, K. W., Li, L., Fuke, Y. and Chan, L. (1997) Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice. Hum. Gene Ther., 8: 1921-1933.